Taking Aim at Cancer
Therapeutic antibodies carry ‘payloads’ to destroy cancer cells.
Progress Against Cancer
Therapeutic antibodies carry ‘payloads’ to destroy cancer cells.
Neurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
Cardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
Technology could help detect lymphedema earlier.
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but...
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
By Kaleem Zaidi, PhDAACR Executive Office The year 2022 marked significant progress against cancer, thanks to advances in cancer...